Increasing the efficiency of your clinical trial authorisation (CTA) application and reducing the need for subsequent substantial amendments
Posted by:
Graham McNaughton and Martin O'Kane, Posted on:
-
Categories:
Behind the Scenes, Clinical Trials
In this blog we describe ways to facilitate the review of your initial application, how to avoid unnecessary amendments and, where substantial amendments are necessary, how to submit these so that the review is as efficient as possible, leading to …